Arcturus Therapeutics Ltd
(ARCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -203,674 | -165,011 | -110,927 | -56,346 | -72,148 |
| Depreciation Amortization | 1,193 | 883 | 594 | 307 | 882 |
| Accounts receivable | -1,242 | 110 | -38 | 118 | 54 |
| Accounts payable and accrued liabilities | -769 | -2,569 | -791 | -5,415 | 4,812 |
| Other Working Capital | 32,625 | 44,301 | 14,667 | 2,094 | 21,216 |
| Other Operating Activity | 36,824 | 29,740 | 20,602 | 16,292 | 2,323 |
| Operating Cash Flow | $-135,043 | $-92,546 | $-75,893 | $-42,950 | $-42,861 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,406 | -2,288 | -522 | -118 | -1,742 |
| Investing Cash Flow | $-3,406 | $-2,288 | $-522 | $-118 | $-1,742 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 46,599 | 46,599 | 46,599 | 46,599 | N/A |
| Common Stock Issued | 1,417 | 1,187 | 495 | 413 | 436,145 |
| Financing Cash Flow | $48,016 | $47,786 | $47,094 | $47,012 | $436,145 |
| Beginning Cash Position | 463,002 | 463,002 | 463,002 | 463,002 | 71,460 |
| End Cash Position | 372,569 | 415,954 | 433,681 | 466,946 | 463,002 |
| Net Cash Flow | $-90,433 | $-47,048 | $-29,321 | $3,944 | $391,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -135,043 | -92,546 | -75,893 | -42,950 | -42,861 |
| Capital Expenditure | -3,406 | -2,288 | -522 | -118 | -1,742 |
| Free Cash Flow | -138,449 | -94,834 | -76,415 | -43,068 | -44,603 |